Balance Labs, Inc. (BLNC)
OTCMKTS · Delayed Price · Currency is USD
1.550
-0.020 (-1.27%)
At close: Nov 26, 2025
Balance Labs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.22 | 0.36 | 0.01 | 0.11 | 0.24 | 0.23 |
Short-Term Investments | 0.01 | 0.04 | 0.08 | 0.11 | 0.15 | 0.55 |
Cash & Short-Term Investments | 0.23 | 0.4 | 0.1 | 0.22 | 0.38 | 0.78 |
Cash Growth | 160.88% | 315.91% | -56.70% | -42.54% | -50.60% | 13707.09% |
Accounts Receivable | 0.03 | - | - | - | 0.05 | 0.02 |
Other Receivables | - | - | - | - | - | 0.01 |
Receivables | 0.03 | - | - | - | 0.05 | 0.2 |
Total Current Assets | 0.26 | 0.4 | 0.1 | 0.22 | 0.43 | 0.98 |
Long-Term Investments | - | - | - | - | - | 0.02 |
Other Long-Term Assets | - | - | - | - | - | 0.02 |
Total Assets | 0.26 | 0.4 | 0.1 | 0.22 | 0.43 | 1.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.42 | 0.36 | 1.72 | 1.38 | 1.22 | 1.01 |
Accrued Expenses | 0.93 | 0.93 | 0.91 | 0.91 | 0.91 | 0.85 |
Short-Term Debt | 0.52 | 0.52 | 2.01 | 2.36 | 1.98 | 1.98 |
Current Portion of Long-Term Debt | 0.03 | 0.03 | 0.53 | 0.11 | - | - |
Other Current Liabilities | 1.24 | 1.94 | - | - | - | 0.1 |
Total Current Liabilities | 3.13 | 3.77 | 5.17 | 4.76 | 4.11 | 3.94 |
Long-Term Debt | - | - | - | - | 0.48 | 0.47 |
Total Liabilities | 3.13 | 3.77 | 5.17 | 4.76 | 4.59 | 4.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 34.6 | 34.27 | 0.81 | 0.81 | 0.81 | 0.81 |
Retained Earnings | -37.47 | -37.65 | -5.88 | -5.36 | -4.97 | -4.21 |
Total Common Equity | -2.87 | -3.38 | -5.07 | -4.54 | -4.16 | -3.39 |
Shareholders' Equity | -2.87 | -3.38 | -5.07 | -4.54 | -4.16 | -3.39 |
Total Liabilities & Equity | 0.26 | 0.4 | 0.1 | 0.22 | 0.43 | 1.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.54 | 0.54 | 2.54 | 2.47 | 2.46 | 2.44 |
Net Cash (Debt) | -0.32 | -0.15 | -2.44 | -2.25 | -2.07 | -1.67 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.11 | -0.10 | -0.10 | -0.08 |
Filing Date Shares Outstanding | 46.85 | 46.85 | 21.67 | 21.67 | 21.67 | 21.67 |
Total Common Shares Outstanding | 46.85 | 46.85 | 21.67 | 21.67 | 21.67 | 21.67 |
Working Capital | -2.87 | -3.38 | -5.07 | -4.54 | -3.68 | -2.96 |
Book Value Per Share | -0.06 | -0.07 | -0.23 | -0.21 | -0.19 | -0.16 |
Tangible Book Value | -2.87 | -3.38 | -5.07 | -4.54 | -4.16 | -3.39 |
Tangible Book Value Per Share | -0.06 | -0.07 | -0.23 | -0.21 | -0.19 | -0.16 |
Machinery | - | 0.01 | 0.01 | - | - | - |